ENVB
Enveric Biosciences Inc
NASDAQ: ENVB · HEALTHCARE · BIOTECHNOLOGY
$3.95
-23.45% today
Updated 2026-04-30
Market cap
$10.01M
P/E ratio
—
P/S ratio
0.08x
EPS (TTM)
$-36.24
Dividend yield
—
52W range
$2 – $18
Volume
5.0M
Enveric Biosciences Inc (ENVB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $896921.00 | $463576.00 | $1.61M | $69675.00 | $1792.00 | $1126.00 | $22450.00 | $5600.00 | $4468.00 | $5085.00 | $13.83M | $39.51M | $52.20M | $29.64M | $25.01M | $4.10M | $26.72M | $19.55M | $4.30M | $3.08M |
| Cash & equivalents | $550633.00 | $228940.00 | $582019.00 | $66833.00 | $1792.00 | $1126.00 | $18231.00 | $1381.00 | $249.00 | $5085.00 | $1.88M | $1.38M | $4.88M | $1.37M | $431400.00 | $1.58M | $17.36M | $17.72M | $2.29M | $2.24M |
| Current assets | $739970.00 | $328841.00 | $1.61M | $69675.00 | $1792.00 | $1126.00 | $22450.00 | $5600.00 | $4468.00 | $5085.00 | $7.18M | $10.06M | $14.64M | $10.06M | $7.60M | $2.28M | $17.74M | $18.43M | $3.58M | $2.73M |
| Total liabilities | $179519.00 | $87075.00 | $47903.00 | $21206.00 | $11867.00 | $50642.00 | $17895.00 | $25666.00 | $24695.00 | $8956.00 | $13.58M | $27.84M | $32.75M | $18.88M | $14.38M | $681250.00 | $4.41M | $4.00M | $2.34M | $1.49M |
| Current liabilities | $179519.00 | $87075.00 | $47903.00 | $21206.00 | $11867.00 | $50642.00 | $17895.00 | $25666.00 | $24695.00 | $8956.00 | $8.58M | $12.71M | $30.37M | $14.69M | $14.38M | $681250.00 | $2.08M | $4.00M | $2.34M | $1.49M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | $2.38M | — | — | — | — | — | — | — |
| Shareholder equity | $717402.00 | $376501.00 | $1.56M | $48469.00 | $-10075.00 | $-49516.00 | $4555.00 | $-20066.00 | $-20227.00 | $-3871.00 | $258533.00 | $11.66M | $19.44M | $10.76M | $10.62M | $3.42M | $22.31M | $14.67M | $1.96M | $1.59M |
| Retained earnings | $-46.18M | $-46.54M | $-45.73M | $-45.87M | $-47.29M | $-47.33M | $-47.37M | $-47.39M | $-47.39M | $-47.43M | $-1.05M | $-3.83M | $-15.00M | $-34.48M | $-40.51M | $-11.76M | $-60.74M | $-79.21M | $-96.50M | $-106.07M |
| Accounts receivable | $155233.00 | $74828.00 | — | — | — | — | — | — | — | — | $4.87M | $8.06M | $8.84M | $7.87M | $6.38M | $6.38M | — | — | $224607.00 | — |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — | $3.47M | $17.09M | $21.90M | $13.73M | $13.73M | $13.73M | $1.59M | $0.00 | — | — |